Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the Bloodwise TAP Clarity study
Authors
Munir, TRawstron, A
Brock, K
Vicente, S
Yates, F
Bishop, R
Macdonald, D
Fegan, C
McCaig, A
Schuh, A
Pettitt, A
Gribben, J
Patten, P
Devereux, S
Bloor, Adrian
Fox, C
Forconi, F
Hillmen, P
Affiliation
St James’s Institute of Oncology, Leeds Teaching HospitalIssue Date
2019